Latest filing published 27 Nov 2007 for RespireRx Pharmaceuticals Inc., €1,655.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark A. Varney: trading record in brief
Mark A. Varney appears in our data through filings on RespireRx Pharmaceuticals Inc. shares, published by SEC (Form 4). Over a trading history stretching from 20 November 2007 to 27 November 2007, the count stands at 5 filings.
No open-market sale appears; the market trades are 5 purchases worth €9,565. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
In size, the median ticket on the buying side is €1,655.
The latest filing, published on 27 November 2007, reports an open-market purchase of €1,655 in RespireRx Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark A. Varney
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$0.49Common StockSEC:0001181431-07-071798:0Canonical exit: 24 Feb 2008 (T+90)
- 1,500 shares@ US$0.48Common StockSEC:0001181431-07-071798:1Canonical exit: 24 Feb 2008 (T+90)
- 12,385 shares@ US$0.48Common StockSEC:0001181431-07-071798:2Canonical exit: 25 Feb 2008 (T+90)
- 7,115 shares@ US$0.46Common StockSEC:0001181431-07-071403:0Canonical exit: 19 Feb 2008 (T+90)
- 4,000 shares@ US$0.45Common StockSEC:0001181431-07-071325:0Canonical exit: 18 Feb 2008 (T+90)
5 of 5 declarations